16-30993489-G-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_052874.5(STX1B):c.538-5C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000542 in 1,613,448 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_052874.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STX1B | NM_052874.5 | c.538-5C>G | splice_region_variant, intron_variant | ENST00000215095.11 | NP_443106.1 | |||
STX1B | XM_017022893.2 | c.520-5C>G | splice_region_variant, intron_variant | XP_016878382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STX1B | ENST00000215095.11 | c.538-5C>G | splice_region_variant, intron_variant | 1 | NM_052874.5 | ENSP00000215095.5 | ||||
STX1B | ENST00000565419.2 | c.538-5C>G | splice_region_variant, intron_variant | 2 | ENSP00000455899.1 |
Frequencies
GnomAD3 genomes AF: 0.000782 AC: 119AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00103 AC: 258AN: 250770Hom.: 3 AF XY: 0.000856 AC XY: 116AN XY: 135554
GnomAD4 exome AF: 0.000517 AC: 756AN: 1461222Hom.: 6 Cov.: 34 AF XY: 0.000495 AC XY: 360AN XY: 726916
GnomAD4 genome AF: 0.000782 AC: 119AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000766 AC XY: 57AN XY: 74430
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 19, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 24, 2018 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Generalized epilepsy with febrile seizures plus, type 9 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at